Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James C. Blair currently holds 20,000 shares of Somaxon Pharmaceuticals, Inc. (SOMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James C. Blair has been a net buyer of SOMX stock. They have purchased $139.2M and sold $66.4M worth of shares.
James C. Blair's most recent insider trade was on Aug 20, 2019, when they purchased 20,000 shares at $5.97 per share.
James C. Blair serves as Executive at Somaxon Pharmaceuticals, Inc. (SOMX). They have executed 306 insider transactions totaling $205.6M over their tenure at the company.
James C. Blair holds the position of Executive at Somaxon Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James C. Blair has shown a buying trading pattern, with $139.2M in total purchases and $66.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James C. Blair was on May 26, 2016, when they sold $1.6M worth of EVOK shares. This transaction involved 344,120 shares at $4.70 per share.
James C. Blair currently owns 20,000 shares of Somaxon Pharmaceuticals, Inc. (SOMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James C. Blair's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James C. Blair has 306 Form 4 filings on record as an insider at Somaxon Pharmaceuticals, Inc..
Set alerts for James C. Blair and 40,000+ other insiders.